Related Experiment Video

Updated: Jul 25, 2026

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

13.0K

Response to IV immunoglobulin in a case of osmotic demyelination syndrome

Suresh Thirunavukarasu1, Asthik Biswas2, Farha Furruqh2

  • 1Department of Neurology, Indira Gandhi Government General Hospital and Post Graduate Institute, Puducherry, India.

BMJ Case Reports
|November 27, 2015
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Osmotic Pump-based Drug-delivery for In Vivo Remyelination Research on the Central Nervous System06:07

Osmotic Pump-based Drug-delivery for In Vivo Remyelination Research on the Central Nervous System

Published on: December 17, 2021

6.1K
Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

1.4K

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...